APA
Du J., Yan L., Torres R., Gong X., Bian H., Marugán C., Boehnke K., Baquero C., Hui Y., Chapman S. C., Yang Y., Zeng Y., Bogner S. M., Foreman R. T., Capen A., Donoho G. P., Van Horn R. D., Barnard D. S., Dempsey J. A., Beckmann R. P., Marshall M. S., Chio L., Qian Y., Webster Y. W., Aggarwal A., Chu S., Bhattachar S., Stancato L. F., Dowless M. S., Iversen P. W., Manro J. R., Walgren J. L., Halstead B. W., Dieter M. Z., Martinez R., Bhagwat S. V., Kreklau E. L., Lallena M. J., Ye X. S., Patel B. K. R., Reinhard C., Plowman G. D., Barda D. A., Henry J. R., Buchanan S. G. & Campbell R. M. (20200707). Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy. : Molecular cancer therapeutics.
Chicago
Du Jian, Yan Lei, Torres Raquel, Gong Xueqian, Bian Huimin, Marugán Carlos, Boehnke Karsten, Baquero Carmen, Hui Yu-Hua, Chapman Sonya C, Yang Yanzhu, Zeng Yi, Bogner Sarah M, Foreman Robert T, Capen Andrew, Donoho Gregory P, Van Horn Robert D, Barnard Darlene S, Dempsey Jack A, Beckmann Richard P, Marshall Mark S, Chio Li-Chun, Qian Yuewei, Webster Yue W, Aggarwal Amit, Chu Shaoyou, Bhattachar Shobha, Stancato Louis F, Dowless Michele S, Iversen Phillip W, Manro Jason R, Walgren Jennie L, Halstead Bartley W, Dieter Matthew Z, Martinez Ricardo, Bhagwat Shripad V, Kreklau Emiko L, Lallena Maria Jose, Ye Xiang S, Patel Bharvin K R, Reinhard Christoph, Plowman Gregory D, Barda David A, Henry James R, Buchanan Sean G and Campbell Robert M. 20200707. Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy. : Molecular cancer therapeutics.
Harvard
Du J., Yan L., Torres R., Gong X., Bian H., Marugán C., Boehnke K., Baquero C., Hui Y., Chapman S. C., Yang Y., Zeng Y., Bogner S. M., Foreman R. T., Capen A., Donoho G. P., Van Horn R. D., Barnard D. S., Dempsey J. A., Beckmann R. P., Marshall M. S., Chio L., Qian Y., Webster Y. W., Aggarwal A., Chu S., Bhattachar S., Stancato L. F., Dowless M. S., Iversen P. W., Manro J. R., Walgren J. L., Halstead B. W., Dieter M. Z., Martinez R., Bhagwat S. V., Kreklau E. L., Lallena M. J., Ye X. S., Patel B. K. R., Reinhard C., Plowman G. D., Barda D. A., Henry J. R., Buchanan S. G. and Campbell R. M. (20200707). Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy. : Molecular cancer therapeutics.
MLA
Du Jian, Yan Lei, Torres Raquel, Gong Xueqian, Bian Huimin, Marugán Carlos, Boehnke Karsten, Baquero Carmen, Hui Yu-Hua, Chapman Sonya C, Yang Yanzhu, Zeng Yi, Bogner Sarah M, Foreman Robert T, Capen Andrew, Donoho Gregory P, Van Horn Robert D, Barnard Darlene S, Dempsey Jack A, Beckmann Richard P, Marshall Mark S, Chio Li-Chun, Qian Yuewei, Webster Yue W, Aggarwal Amit, Chu Shaoyou, Bhattachar Shobha, Stancato Louis F, Dowless Michele S, Iversen Phillip W, Manro Jason R, Walgren Jennie L, Halstead Bartley W, Dieter Matthew Z, Martinez Ricardo, Bhagwat Shripad V, Kreklau Emiko L, Lallena Maria Jose, Ye Xiang S, Patel Bharvin K R, Reinhard Christoph, Plowman Gregory D, Barda David A, Henry James R, Buchanan Sean G and Campbell Robert M. Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy. : Molecular cancer therapeutics. 20200707.